IPC’s global network includes Councilors and Jr. Councilors, who are volunteer leaders advancing psoriasis care worldwide. With 200+ experts globally, their work spans research, education, and clinical practice across disciplines like genetics, epidemiology, psychology, patient care, and more.
Learn more about our global volunteer network by searching the Meet the Experts directory.
IPC Councilors are leading experts in psoriasis who volunteer their time to support IPC’s mission through research, education, and global collaboration to improve patient care.
IPC Jr. Councilors are alumni of the IPC International Fellowship Program who continue to contribute to our mission. As emerging leaders in dermatology, they support IPC’s work through education, research, and global outreach alongside senior Councilors.
The IPC Councilor Emeritus designation is an honorary title recognizing Councilors and former Board Members who are transitioning from active professional roles and whose leadership and service have made a significant and lasting contribution to advancing IPC’s mission.
A new IPC paper in JAAD presents five priorities for improving metabolic screening, advancing GLP-1 research in the context of psoriasis, and defining the dermatologist’s role in managing cardiometabolic risk in psoriasis patients.
IPC Jr. Councilor Mio Nakamura speaks with Dr. John Koo about how personality traits, including borderline personality disorder, shape clinical interactions and shares practical strategies for dermatologists to build stronger patient relationships.
Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.
The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.
Rare ADAR1 gene mutations drive a distinct, interferon-fueled psoriasis subtype, and it responds to JAK1 and TYK2 inhibitors rather than standard IL-17/IL-23 biologics.
IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.
IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.
